Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 2/20 | 0.37 |
| ▸ | GAA | P10253 | 1/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.34 |
| ▸ | TP53 | P04637 | 1/20 | 0.34 |
| ▸ | RAPGEF4 | Q8WZA2 | 3/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | ALPL | P05186 | 1/20 | 0.32 |
| ▸ | CA9 | Q16790 | 1/20 | 0.32 |
| ▸ | MAOA | P21397 | 1/20 | 0.31 |
| ▸ | MAOB | P27338 | 1/20 | 0.31 |
| ▸ | NPC1 | O15118 | 2/20 | 0.31 |
| ▸ | RAB9A | P51151 | 2/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | ELANE | P08246 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.30 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | HPGD | P15428 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
| ▸ | POLB | P06746 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15453986 | 0.85 | ALDH1A1 (0.34) | MAPTGAATDP1TP53RAPGEF4 | |
| SCHEMBL8064215 | 0.77 | MAPT (0.37) | MAPTGAATDP1TP53LMNA | |
| SCHEMBL3043421 | 0.76 | TDP1 (0.52) | MAPTGAATDP1TP53RAPGEF4 | |
| SCHEMBL31547677 | 0.76 | TDP1 (0.52) | MAPTGAATDP1TP53RAPGEF4 | |
| SCHEMBL6425763 | 0.74 | GAA (0.35) | MAPTGAATDP1TP53RAPGEF4 | |
| SCHEMBL8465845 | 0.74 | ACHE (0.35) | TDP1MAOBNPC1RAB9AMEN1 | |
| SCHEMBL23967969 | 0.73 | MAPT (0.42) | MAPTGAATDP1TP53RAPGEF4 | |
| SCHEMBL20554010 | 0.72 | MAPT (0.39) | MAPTGAATDP1TP53RAPGEF4 | |
| SCHEMBL10939076 | 0.72 | MAPT (0.39) | MAPTGAATDP1TP53RAPGEF4 | |
| SCHEMBL5147351 | 0.72 | TRPA1 (0.37) | RAPGEF4CA9ALDH1A1SMN1; SMN2CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10376869-B2 | Process for oligomerization | DOW GLOBAL TECHNOLOGIES LLC (US) | 2019-08-13 | — | — | US | disclosed |
| US-20180154344-A1 | PROCESS FOR OLIGOMERIZATION | DOW GLOBAL TECHNOLOGIES LLC (US) | 2018-06-07 | — | — | US | disclosed |
| US-9133370-B2 | Methods of mercaptanizing olefinic hydrocarbons and compositions produced therefrom | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2015-09-15 | — | — | US | disclosed |
| US-20130240780-A1 | Methods of Mercaptanizing Olefinic Hydrocarbons and Compositions Produced Therefrom | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2013-09-19 | — | — | US | disclosed |
| US-8148545-B2 | Processes for the synthesis of γ nitrocarbonyl and γ dicarbonyl compounds and their pyrrole derivatives | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2012-04-03 | — | — | US | disclosed |
| US-20120064322-A1 | AMINOPLAST-POLYTHIOL COMPOSITIONS AND ARTICLES PRODUCED THEREFROM | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2012-03-15 | — | — | US | disclosed |
| US-20120035291-A1 | METHODS OF MERCAPTANIZING OLEFINIC HYDROCARBONS AND COMPOSITIONS PRODUCED THEREFROM | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2012-02-09 | — | — | US | disclosed |
| EP-0212907-B1 | PROCESS FOR FABRICATING OPTICAL RECORDING MEDIA | MITSUI TOATSU CHEMICALS, Inc. (JP) | 1991-03-13 | — | — | EP | disclosed |
| EP-0203826-B1 | OPTICAL RECORDING MEDIUM AND METHOD OF RECORDING THEREON | MITSUI TOATSU CHEMICALS, Inc. (JP) | 1991-03-06 | — | — | EP | disclosed |
| US-4798781-A | PHTHALO/NAPHTHALOCYANINE DYE/ | MITSUI TOATSU CHEMICALS, INCORPORATED (JP) | 1989-01-17 | — | — | US | disclosed |
| US-4766054-A | CONTAINING PHTHALO(NAPHTHALO)CYANINE DYE | MITSUI TOATSU CHEMICAL, INC. (JP) | 1988-08-23 | — | — | US | disclosed |
| EP-0212907-A2 | Process for fabricating optical recording media | MITSUI TOATSU CHEMICALS, Inc. (JP) | 1987-03-04 | — | — | EP | disclosed |
| EP-0203826-A2 | Optical recording medium and method of recording thereon | MITSUI TOATSU CHEMICALS, Inc. (JP) | 1986-12-03 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10376869-B2 | Process for oligomerization | OXER1, NOD1, LIG1 | MAPT 2631/4885GAA 3107/4885TDP1 273/4885 |
| US-20180154344-A1 | PROCESS FOR OLIGOMERIZATION | OXER1, NOD1, LIG1 | MAPT 2631/4885GAA 3107/4885TDP1 273/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.